World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Wang HY, Qi MM, Zhang K, Zhu YZ, Zhang J. Dopamine receptor D1-mediated suppression of liver fibrosis via Hippo/Yes-associated protein 1 signaling in levodopa treatment. World J Gastroenterol 2025; 31(34): 108617 [PMID: 40937451 DOI: 10.3748/wjg.v31.i34.108617]
URL:	https://www.wjgnet.com/1007-9327/full/v31/i34/108617.htm

Number	Citing Articles
1	Zhi-Gang Liu, Shan-Shan Xie. Levodopa and the dopamine receptor D1-Hippo/yes-associated protein axis: A novel therapeutic avenue for liver fibrosis. World Journal of Gastroenterology 2025; 31(46): 113298 doi: 10.3748/wjg.v31.i46.113298 Abstract(87) \| Core Tip(80) \| Full Article(HTML)(386) \| Full Article (PDF)-385K(77) \| Full Article with Cover (PDF)-732K(49) \| Full Article (XML)-82K(42) \| Audio-1333K(20) \| Peer-Review Report-249K(36) \| Answering Reviewers-125K(180) \| Times Cited (0) \| Total Visits (617) \| Open
2	Donglin Hao, Yuebo Hu, Wei Luo, Shihui Li, Yongmin Yan, Jing Zhou. Liver-nervous system axis: pathways, dysregulation, and translational perspectives. Journal of Neuroinflammation 2026; 23(1) doi: 10.1186/s12974-026-03875-3
3	Jun Xu, Ying Qian, Jun-Min Wang, Xing-Li Wu, Yi-Yuan Zheng. Levodopa: A novel therapeutic prospect for liver disease. World Journal of Hepatology 2026; 18(2): 115563 doi: 10.4254/wjh.v18.i2.115563 Abstract(154) \| Core Tip(72) \| Full Article(HTML)(319) \| Full Article (PDF)-782K(74) \| Full Article with Cover (PDF)-1080K(112) \| Full Article (XML)-42K(52) \| Audio-738K(10) \| Peer-Review Report-290K(30) \| Answering Reviewers-150K(43) \| Times Cited (0) \| Total Visits (674) \| Open